NAME William
W. Quick, MD, FACP, FACE
LOCATION North Charleston, South
Carolina, USA
SUMMARY
Dr. Quick is an
endocrinologist, insulin pumper, and medical writer. He is a
nationally-known expert in diabetes education, and is a past president of the
American Association of Diabetes Educators. He is board-certified in both
internal medicine and in endocrinology and metabolism, and is a Fellow of the
American College of Physicians and a Fellow of the American College of
Endocrinology.
He has written
about diabetes on the Internet since 1995,
and is co-author of a new diabetes website launched in March 2012: D-is-for-Diabetes.com
Dr. Quick has 30+ years of clinical experience including over
a dozen years in pharmaceutical medicine with Parke-Davis, Pfizer, Aventis,
Sanofi-Aventis, Schering-Plough, and with i3 Research and i3 Drug Safety. Prior
to joining the pharmaceutical industry, he served in the USPHS in Alaska, was
Associate Professor of Internal Medicine at the University of South Dakota, and
was in private practice of endocrinology, with an emphasis on diabetes care. He
has been active in the ADA for more than 30 years, and is a Past President of
the American Association of Diabetes Educators, and has been a member of DIA,
AACE, the Endocrine Society, and the American College of Physicians.
EDUCATION
1971-1972 Fellowship,
Endocrinology
University of
Missouri Medical Center
Columbia, MO, USA
1968-1971 Internship and
Residency, Internal Medicine
University of
Missouri Medical Center
Columbia, MO, USA
1968 Doctor
of Medicine
State University of
NY
New York, USA
1964 Bachelor
of Arts
College of Wooster
Wooster, OH, USA
PROFESSIONAL EXPERIENCE
2006 - present Writer about diabetes
(part-time)
HealthCentral.com
June 2011 - October 2011 Vice
President Drug Safety
i3 Drug Safety
Basking
Ridge, NJ, USA
May
2010 - June 2011 Senior Medical
Director & Head, Medical Safety Services
i3
Drug Safety
Basking Ridge, NJ, USA
2008 - May 2010 Executive
Medical Director for the Americas, Endocrinology & Metabolic Disease
Medical
& Scientific Affairs, i3 Research
Basking Ridge, NJ, USA
2007 - 2008 Senior
Medical Director, Endocrinology & Metabolic Disease
Medical
& Scientific Affairs, i3 Research
Basking Ridge, NJ, USA
2005 - 2007 Director,
Global Pharmacovigilance and Head, Case Review Physicians Group - Global
Pharmacovigilance
Schering-Plough
Research Institute
Springfield,
NJ, USA
2001 - 2005 Associate
Director, Global Pharmacovigilance and Epidemiology
Sanofi-Aventis (formerly Aventis
Pharmaceuticals)
Bridgewater,
NJ, USA
1998 - 2001 Associate
Medical Director, Drug Safety Surveillance
Pfizer
Inc. (formerly Parke-Davis Pharmaceutical Research)
Ann
Arbor, MI, USA
1997 - 1998 Medical
Staff (part-time)
Missouri
State Board of Registration for the Healing Arts
Jefferson
City, MO, USA
1986 - 1998 Private
Practice Physician (Endocrinology)
Midwest
Diabetes Care Center
Kansas
City/Independence, MO, USA
1985 - 1986 Private
Practice Physician (Endocrinology)
Midwest
Diabetes and Endocrinology Center
West
Des Moines, IA, USA
1981 - 1985 Private
Practice Physician (Endocrinology)
Downtown
Yankton Medical Clinic
Yankton,
SD, USA
1978 - 1985 Director
of Medical Services (part-time)
South
Dakota Human Services Center
Yankton,
SD, USA
1978 - 1985 Associate
Professor of Internal Medicine and Psychiatry (part-time)
University
of South Dakota School of Medicine
Vermillion,
SD, USA
1974 - 1981 Private
Practice Physician (Internal Medicine)
Yankton
Medical Clinic (formerly Yankton Clinic, PA)
Yankton,
SD, USA
1972 - 1974 Deputy Chief of
Medicine, Department of Internal Medicine
US
Public Health Service, Alaska Native Medical Center
Anchorage,
AK, USA
LICENSURE/CERTIFICATION
1986 to Present Medical License
State of Missouri
(Previous medical
licenses in Iowa, Kansas, Nebraska, and South Dakota, all now inactive or not
renewed)
1994 Fellow
American College of
Endocrinology
1986, 1992, 1997 Certified
Diabetes Educator
National
Certification Board for Diabetes Educators
1977 Fellow
American College of
Physicians
1977 Certification
Subspecialty
Board on Endocrinology, Diabetes and Metabolism
American Board of Internal
Medicine
1974 Certification
American Board of
Internal Medicine
PROFESSIONAL INTERESTS
Diabetes Education and Diabetes Care
Medical Education
Drug Safety
Medical Applications of Computers
Recent Attendance at Professional Meetings
PROFESSIONAL MEMBERSHIPS
1991 to Present American Association of
Clinical Endocrinologists
Charter Member
1979
to Present American
Association of Diabetes Educators
1994
to Present American
College of Endocrinology
1972
to Present American
College of Physicians
1972
to Present American
Diabetes Association
1999
to Present Drug
Information Association
2004
to Present Endocrine
Society
ABSTRACTS
Quick
WW, et al. Reporting Rate of Jaundice/Hyperbilirubinemia
in Troglitazone Treated Patients Has Decreased. American Association of
Clinical Endocrinologists, May 2000, Atlanta, GA
Quick
WW, et al. Reporting Rate of Liver Transplant and Death with Troglitazone Has
Decreased. American Diabetes Association, June 2000, San Antonio, TX
Huang EA, Zdon GS, Moore RJ, Moran HJ,
Reidel V, Quick WW. Trends in early metformin monotherapy for newly diagnosed type 2
diabetes in the United States, 2001-2007. American Diabetes Association, June
2009, New Orleans, LA
PUBLICATIONS
Quick WW. Diagnosis of diabetes: use of the oral glucose tolerance test. Mo
Med. 1972 Apr;69(4):275-7
Quick WW. Filing and retrieving medical literature. JAMA.
1979 Aug 24-31;242(8):710-1.
Quick WW. Pathophysiology
of Diabetes. In Diabetes Education: A Core Curriculum for Health
Professionals, American Association of Diabetes Educators, 1988; Second
Edition, 1993
Zhang
Y, Dall TM, Mann SE, Chen Y, Martin J, Moore V, Baldwin A, Reidel VA, Quick WW. The Economic Cost of Undiagnosed Diabetes.
Population Health Management. 2009, 12(2): 95-101.
Dall TM, Mann SE, Zhang Y, Quick WW, Seifert
RF, Martin, J, Huang EA, Zhang, S. Distinguishing the Economic Costs Associated
with Type 1 and Type 2 Diabetes. Population Health
Management. 2009, 12(2): 103-110.
Zhang Y, Dall TM, Chen Y, Baldwin A,
Yang W, Mann SE, Moore V, Le Nestour E, Quick WW.
Medical Cost Associated with Pre-Diabetes. Population Health
Management. 2009, 12(3): 157-163.
Chen Y,
Quick WW, Yang W, Zhang Y, Baldwin A, Moran J, Moore V, Sahai
N, Dall TM. Cost of Gestational Diabetes Mellitus in the U.S. in 2007. Population Health Management. 2009, 12(3): 165-174.
Huang EA, Zdon
GS, Moore RJ, Moran HJ, Quick WW. The
impact of publishing medical specialty society guidelines on subsequent
adoption of best practices: a case study with type 2 diabetes. Int J Clin Pract.
2010, 64(5): 558-561.
Dall
TM, Zhang Y, Chen YJ, Quick WW, Yang WG,
Fogli J. The Economic Burden Of Diabetes. Health Affairs. 2010, 29(2): 1-7.